Keywords
nurses
patients with thalassemia
Saudi Arabia
treatment adherence
Abstract
DISEASE KNOWLEDGE AND TREATMENT ADHERENCE AMONG ADULT PATIENTS WITH THALASSEMIA: A CROSS-SECTIONAL CORRELATIONAL STUDY
Aim. To investigate the disease knowledge and treatment adherence among adult patients with thalassemia.
Material and methods. A cross-sectional correlational study was carried out with a convenience sample of 100 adult patients with thalassemia from a university teaching hospital in Jeddah city, Saudi Arabia. The Disease Knowledge about Thalassemia Major, the Treatment Adherence Scale, and sociodemographic survey were completed by participants. The data were analyzed using Statistical Package for the Social Sciences version 22. Descriptive and inferential statistics and Pearson correlations were performed.
Results. The participants had a moderate level of disease knowledge (M = 15.59, SD = 2.30) and a low level of treatment adherence (M = 3.91, SD = 1.83). There was also a weak but significant positive relationship between disease knowledge and treatment adherence (r = 0.297, P = 0.041). A significant difference in treatment adherence mean scores was found among participants with different monthly incomes (P = 0.05).
Conclusions. Knowledge gained from this study may be useful in improving nurses’ understanding of the effects of providing practical knowledge on treatment adherence. Educational strategies/interventions programs may be required to improve knowledge and adherence to treatment among thalassemia patients. Longitudinal studies are also needed to test for moderators and mediators of relationships of disease knowledge and treatment adherence.
References
1. Cao A, Galanello R. Beta-Thalassemia. Genet Med. 2010;19(6):61-76. doi:10.1038/gim.2016.173
2. Al-Kloub MI, Abed MA, Al khawaldeh OA, et al. Predictors of non-adherence to follow-up visits and deferasirox chelation therapy among Jordanian adolescents with thalassemia major. Pediatr Hematol Oncol. 2014;13(7):624-637. https://doi.org/10.3109/08880018.2014.939792.
3. Alenazi SA, Ali HW, Alharbi MG, et al. Prevalence of thalassemia and sickle cell disease in Northern border region of Saudi Arabia. Kashmir J Med Sci. 2015;1(1):3-6.
4. Memish ZA, Owaidah TM, Saeedi MY. Marked regional variations in the prevalence of sickle cell disease and beta-thalassemia in Saudi Arabia: Findings from the premarital screening and genetic counseling program. J Epidemiol Glob Health. 2011;1(1):61-68. https://doi.org/10.1016/j.jegh.2011.06.002.
5. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: A systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1459-1544. https://doi.org/10.1016/S0140-6736(16)31012-1
6. Alsaeed ES, Farhat GN, Assiri AM, et al. Distribution of hemoglobinopathy disorders in Saudi Arabia based on data from the premarital screening and genetic counseling program, 2011–2015. J Epidemiol Glob Health. 2018;7(1):S41-S47. https://doi.org/10.1016/j.jegh.2017.12.001
7. Olwi DI, Merdad LA, Ramadan EK. Thalassemia: a prevalent disease yet unknown term among college students in Saudi Arabia. J Community Genet. 2018;9(3):277-282. https://doi.org/10.1007/s12687-017-0351-3.
8. Kingdom of Saudi Arabia-Ministry of Health (MOH). Response to medical advice offered by the healthy marriage program on the rise. Retrieved March 9, 2019, from http://www.moh.gov.sa/en/
9. Trachtenberg FL, Mednick L, Kwiatkowski JL, et al. Beliefs about chelation among thalassemia patients. Health Qual Life Out. 2012;10:148. doi:10.1186/1477-7525-10-148.
10. Burkhart PV, Sabaté E. Adherence to long-term therapies: Evidence for action. J Nurs Scholarsh. 2003;35(3):207.
11. Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004;89(10):1187-1193.
12. Lemay J, Waheedi M, Al-Sharqawi S, Bayoud T. Medication adherence in chronic illness: Do beliefs about medications play a role? Patient Prefer Adherence. 2018;12:1687-1698. https://doi.org/10.2147/PPA.S169236.
13. Pakbaz Z, Treadwell M, Yamashita R, et al. Quality of life in patients with thalassemia intermediary compared to thalassemia major. Ann N Y Acad Sci. 2005;1054:457-461. https://doi.org/10.1196/annals.1345.059.
14. Awwad O, Akour A, Al-Muhaissen S, Morisky D. The influence of patients’ knowledge on adherence to their chronic medications: A cross-sectional study in Jordan. Int J Clin Pharmacol Ther. 2015;37(3):504-510. doi:10.1007/s11096-015-0086-3.
15. Lee YL, Lin DT, Tsai SF. Disease knowledge and treatment adherence among patients with thalassemia major and their mothers in Taiwan. J Clin Nurs. 2009;18(4):529-538. https://doi.org/10.1111/j.1365-2702.2007.02150.x.
16. Yang HC, Chen YC, Mao HC, Lin KH. Illness knowledge, social support and self care behavior in adolescents with beta-thalassemia major. Hu Li Yan Jiu=Nursing Research 2001;9:114-124. (Original Work Published in Chinese)
17. Patton DE, Hughes CM, Cadogan CA, Ryan CA. Theory-based interventions to improve medication adherence in older adults prescribed polypharmacy: A systematic review. Drugs Aging. 2017;34(2):97-113. https://doi.org/10.1007/s40266-016-0426-6.
18. Vardaki MA, Philalithis AE, Vlachonokolis I. Factors associated with the attitudes and expectations of patients suffering from beta-thalassemia: A cross-sectional study. Scand J Caring Sci. 2004;18(2):177-187. https://doi.org/10.1111/j.1471-6712.2004.00267.x.
19. Nazir SU, Hassali AM, Saleem F, et al. Disease related knowledge, medication adherence and glycaemic control among patients with type 2 diabetes mellitus in Pakistan. Prim Care Diabetes. 2016;10(2):136-141. https://doi.org/10.1016/j.pcd.2015.09.004.
20. Patel AP, Parmar PH, Patel RB, et al. Factors influencing beta-thalassemia awareness in Western India. Natl J Community Med, 2016;7(3):193-197.
21. Colah R, aItalia K, Gorakshakar A. Burden of thalassemia in India: The road map for control. Pediatr Hematol Oncol J. 2017;2(4):79-84. https://doi.org/10.1016/j.phoj.2017.10.002
22. Kourorian Z, Azarkeivan A, Hajibeigi B, et al. The effect of knowledge, attitude and practice on the function of thalassemia patients. Iranian Journal of Blood and Cancer. 2014;6(4):177-181.
23. Maheen H, Malik F, Siddique B, Qidwai, A. Assessing parental knowledge about thalassemia in a thalassemia center of Karachi, Pakistan. J Genet Couns. 2015;24(6):945-951. https://doi.org/10.1007/s10897-015-9830-z.
24. Kosaryan M, Vabidshabi K, Siami R, et al. Knowledge, attitudes, and practices of reproductive behaviours in Iranian minor thalassemia couples. Saudi Med J. 2009;30(6):835-839.
25. Abolghasemi H, Amid A, Zeinali S, et al. Thalassemia in Iran: Epidemiology, prevention, and management. J Pediatr Hematol Oncolo. 2007;29(4):233-238. https://doi.org/10.1097/MPH.0b013e3180437e02.
26. Hinkle JL, Cheever KH. Brunner and Suddarath text book of medical surgical nursing. 14th Ed. Lippincott Williams & Wilikins: Philadelphia; Pa; 2017.
27. Pedram M, Zandian K, Keikhaie B, et al. A report on chelating therapy and patient compliance by determination of serum ferritin levels in 243 thalassemia major patients. Iran J Pediatr Society. 2010;2:65-69.
28. Zeydi AE, Moonaghi HK, Heydari A. Exploring Iranian β-Thalassemia major patients’ perception of barriers and facilitators of adherence to treatment: A qualitative study. Electron Physician. 2017;9(12):6102-6110. https://doi.org/10.19082/6102.
29. Pai ALH, Ostendorf HM. Treatment adherence in adolescents and young adults affected by chronic illness during the health care transition from pediatric to adult health care: A literature review. Child Health Care. 2011;40(1):16-33.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Unported License.
Copyright (c) 2019 Authors